Skip to main content

Table 4 Summary of tolerability data during the treatment phase.

From: The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open- label study

 

Baseline

Week 2

Week 4

Week 12

Statistics

p value

SAS

4.3 (5.9)

2.2 (4)

2.1 (3.7)

2 (3.7)

F (3,77) = 5.1

<0.001

BAS

2.2 (3.2)

1.5 (2.8)

1.3 (2.2)

1.3 (2.2)

F (3,77) = 2.2

0.09

AIMS

3.8 (5.9)

2.5 (4.8)

2.1 (3.9)

1.8 (4.1)

F (3,77) = 5.0

<0.001

Weight (kg,)

70.7 (13.5)

70.5 (12.9)

70.9 (13.2)

71.4 (13.2)

F (3,77) = 2.3

0.08

  1. Mean (S.D.)
  2. SAS, Total score of the Simpson Angus scale
  3. BAS, Total Score of the Barnes akathisia scale
  4. AIMS, Total score of the abnormal involuntary movements scale